The debate in Europe over Biden's proposal for a waiver on Covid-19 vaccine patents
Under growing pressure, the head of the European commission, Ursula von der Leyen, said on Thursday that the EU is “ready to discuss” President Biden’s proposal to waive Covid-19 vaccine patents, but did not endorse it. The US decision to drop its objections to a patent waiver was received as a seismic shift in Europe. Supporters of the plan say it would allow more manufacturers to produce vaccines, arguing that this will increase access to vaccines in poorer countries. Opponents, including drug makers, say it may not have the desired effect.
Yannis Palaiologos, Kathimerini’s Brussels correspondent, joins The Greek Current to break down the debate in Europe over President Biden’s proposal to waive vaccine patents.
You can read the articles we discuss on our podcast here:
Biden’s Support for Vaccine Patent Waivers Faces Uphill Effort in Europe
US shift on vaccines embarrasses Europe before India summit
Germany rejects US-backed proposal to waive vaccine patents
Will Turkey’s efforts to woo Egypt yield fruit?
Egypt and Turkey hold ‘frank’ official talks, first since 2013